ASTRONCT04439032
Artoss Prospective Spine Registry Outcomes
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 14 versions: 13 with changes below, 1 re-verified with no change. See every version on ClinicalTrials.gov ↗
- Notable Eligibility criteria expanded, about 15 words
- Trial completed
- Minor Primary completion date changed from estimate of Jun 2024 to Oct 31, 2024
- Study completion date: Dec 2024 to Jun 30, 2025
- Minor Primary completion date: Dec 2023 to Jun 2024
- Study completion date: Jun 2024 to Dec 2024
- Minor Trial status: Recruiting to Active, Not Recruiting
- Enrollment target: estimated 250 to confirmed 330
- Site details revised at 6 of 6 sites
- Minor Study sites revised (6)v9
Show 7 earlier versionsHide 7 earlier versions
- Minor Study sites: 4 to 6v8
- Minor Site contacts updated at 4 of 4 sitesv7
- Minor Study sites: 5 to 4v6
- Minor Study sites: 3 to 5
- Start date changed from estimate of Aug 1, 2020 to Aug 3, 2020
- Minor Study sites revised (3)v4
- Minor Study sites: 1 to 3v3
- Notable Start date: Jun 2020 to Aug 1, 2020v2
- Study First Submitted
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
Radiographic Success
Timeframe: 12-months
Secondary (1)
Safety Evaluation
Arms and interventions
Spine Fusion using NanoBone
All patients in the study will be drawn from the individual surgeons' practice. Patients will be candidates for spinal fusion surgery after having failed conservative treatment or will have had spinal fusion surgery but have not completed their standard of care follow-up as determined by the surgeon's practice. In addition, the surgeon has determined that the use of a NanoBone product is or was clinically necessary for the patient.
Other: NanoBone Bone Graft Substitute
Sites
6 sites in 1 country